S
Seacoast Kidney and Hypertension Specialists | Portsmouth, NH
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Empagliflozin
Clazakizumab
BI 690517
Vicadrostat
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
Locations recently updated
This study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse. People who have taken a specific type of medication...
Enrolling
Chronic Kidney Disease
Drug: Vicadrostat
Drug: Empagliflozin
This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...
Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300
Locations recently updated
This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study....
Enrolling
Kidney Disease, Chronic
Drug: Placebo matching BI 690517
Drug: Empagliflozin
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems